English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Short-term use of hormone replacement therapy associated with increased ovarian cancer risk
Short-term use of hormone replacement therapy associated with increased ovarian cancer risk
Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy
Patients with detectable PSA post-prostatectomy should receive more aggressive radiation therapy
Long-term use of hormonal contraceptives is associated with an increased risk of brain tumours
Long-term use of hormonal contraceptives is associated with an increased risk of brain tumours
High-dose testosterone therapy helps some men with advanced prostate cancer
High-dose testosterone therapy helps some men with advanced prostate cancer
Radiation plus hormone therapy prolongs survival for older men with prostate cancer
Radiation plus hormone therapy prolongs survival for older men with prostate cancer
SABCS 2014: Eribulin in combination with capecitabine provides clinical benefit for women with metastatic breast cancer
SABCS 2014: Eribulin in combination with capecitabine provides clinical benefit for women with metastatic breast...
SABCS 2014: IBIS-I trial finds tamoxifen lowered breast cancer rates among high-risk women
SABCS 2014: IBIS-I trial finds tamoxifen lowered breast cancer rates among high-risk women
SABCS 2014: Adding ovarian suppression to tamoxifen reduced recurrence for some women with premenopausal breast cancer
SABCS 2014: Adding ovarian suppression to tamoxifen reduced recurrence for some women with premenopausal breast...
Enzalutamide now approved in Europe for the treatment of chemotherapy-naïve men with metastatic castration-resistant prostate cancer
Enzalutamide now approved in Europe for the treatment of chemotherapy-naïve men with metastatic castration...
The leading oncology channel goes for gold
The leading oncology channel goes for gold
<1...8182838485...105>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top